Atherosclerosis, a disease of the large arteries, is the primary cause of heart disease and stroke. The abnormal proliferation of vascular smooth muscle cells (VSMCs) in arterial walls is an important pathogenetic factor of vascular disorders like atherosclerosis and restenosis after angioplasty. In the present study, the possible antiproliferative effect of a synthetic 1,4-naphthoquinone derivative, 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304) was investigated on rat aortic VSMCs. NQ304 was shown to potently inhibit 5% fetal bovine serum ( 
Several cytokines are involved in the development of atherosclerotic lesions. VSMC proliferation induced by growth factors, such as platelet-derived growth factor (PDGF), is known to be a prerequisite of the intimal thickening that is observed after angioplasty, and mitogen-activated protein kinases (MAPKs) are considered to be a critical step in the proliferation of VSMCs. 1, 2) Pyles et al. reported that MAPKs are activated in response to balloon stretch injury in porcine carotid arteries. 3) Moreover, it has been demonstrated using a carotid artery balloon injury model that MAPK signaling, particularly ERK1/2 signaling, is increased and that medial cell replication following injury is reduced by PD098059. 4) The Akt, a serine/threonine kinase is another important pathway triggered by growth factors, and the activity of Akt has been shown to be stimulated by growth factors acting through receptor tyrosine kinases such as PDGF, epidermal growth factor (EGF), and insulin receptors, and the activation of Akt/PKB by these growth factors has been shown to be mediated by PI3K. [5] [6] [7] The signaling pathway from PI3K to Akt/protein kinase B (PKB) was implicated in some cellular responses of PI3K including protection from apoptosis. 8, 9) Activation of MAPKs transiently stimulates c-fos mRNA expression, which is responsible for the increased VSMC proliferation associated with the development of atherosclerotic disease. 10) AP-1, a transcriptional factor is also required for cell proliferation and tumor progression, and it is also known to regulate the c-fos mRNA expression. 11) After vascular injury, VSMCs are stimulated to divide in response to mitogens, and that they exit G1 and enter the S phase. 12) Recent studies have implicated p27 kip1 and p21 cip1 as inhibitors of cell-cycle progression by associating them with the growth inhibitory effects of antiproliferative agents. Cyclin-dependent kinase inhibitors (CKIs), such as p27 kip1 and p21 cip1 , inactivate cyclin-CDK complexes in the G 1 phase, and are upregulated during arterial repair whereupon they negatively regulate VSMC growth. 13, 14) Compounds with a 1,4-naphthoquinone backbone have many biological and pharmacological effects, i.e., antiviral, antifungal, anticancer, and antiplatelet activities. [15] [16] [17] [18] [19] [20] [21] In previous study, we reported that NQ304, a newly synthesized 1,4-naphthoquinone derivative, has potent antithrombotic effect in mice in vivo, and antiplatelet activities in vitro and ex vivo. 22, 23) However, a synthetic 1,4-naphthoquinone analogue, 2-(2-mercaptoethanol)-3-methyl-1,4-naphthoquinone, was reported to potently inhibit tumor cell growth and to arrest cell cycle progression at G 1 and G 2 /M. 24 ) Therefore, we sought to determine whether NQ304 can also suppress VSMC proliferation. In this study, we provide evidences that NQ304 potently inhibits VSMC proliferation and that it inhibits the ERK1/2 and PI3K/Akt signaling pathways in VSMCs. Our results reveal that NQ304 is a potential agent for the treatment of vascular disorders like atherosclerosis.
MATERIALS AND METHODS
Materials 2-Chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304) compound was kindly provided by Dr. Chung-Kyu Ryu (Ewha Women's University, Seoul).
25)

Potent Inhibition of Serum-Stimulated Responses in Vascular Smooth
Muscle Cell Proliferation by 2-Chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone, a Newly Synthesized 1,4-Naphthoquinone Derivative NQ304 was dissolved in dimethylsulfoxide (DMSO) and added to Dulbecco's modified Eagle's medium (DMEM) with a maximum final DMSO concentration of 0.05%. Cell culture materials were purchased from Gibco-BRL (MD, U.S.A.). The phospho-ERK1/2, ERK1/2, phospho-Akt, and Akt antibodies were purchased from New England Biolabs (MA, U.S.A.). The other chemicals used in the experiments were of the highest analytical grade commercially available.
Cell Culture Rat aortic vascular smooth muscle cells (VSMCs) were isolated by enzymatic dispersion, as previously described 10) according to a modification of the method described by Chamley et al. 26) Cells were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, 8 mM HEPES and 2 mM L-glutamine at 37°C in an humidified 95% air/5% CO 2 incubator. The purity of VSMCs in culture was confirmed immunocytochemically based on a-smooth muscle actin localization. VSMCs at passages 4 to 8 were used in this experiment.
Cell Counts Rat aortic VSMCs were seeded onto 12-well culture plates at 1ϫ10 5 cells/ml, and then cultured in DMEM containing 10% FBS at 37°C for 24 h. Under these conditions, a cell confluence of 70% was reached. The medium was then replaced with serum-free medium containing NQ304, and cells were then stimulated with 5% FBS and trypsinized using trypsin-EDTA, and counted using a hemocytometer. 3 H]-thymidine was extracted into 250 ml of 0.5 M NaOH/well, and this solution was mixed with a 3 ml scintillation cocktail (Ultimagold, Packard Bioscience, CT, U.S.A.). The mixed solution was quantified using a liquid scintillation counter (LS3801, Beckman, Düsseldorf, Germany), and 50 ml of residual solution was measured using a BCA Protein Assay Reagent Kit (Pierce Biotechnology).
DNA
Analysis of Cellular DNA Contents by Flow Cytometry Rat aortic VSMCs were trypsinized and cells were centrifuged at 150ϫg for 10 min. The centrifuged pellets so obtained were suspended in a 5 ml sample buffer (1 g/l glucose in PBS, filtered through a 0.22 mm filter) and washed twice. The centrifuged pellets were then suspended in 70% ethanol and fixed overnight at 4°C. Fixed cells were briefly vortexed and centrifuged at 400ϫg for 5 min. The ethanol was then discarded and cells were stained with 0.5 ml of propidium iodide (PI) solution (50 mg/ml PI in sample buffer containing 100 mg/ml of RNase A), and each sample was then incubated for 30 min at room temperature. The PI-DNA complex in each cell nucleus was measured using a FACSCalibur (Becton & Dickinson Co., U.S.A.). The rate of G 0 /G 1 , S and G 2 /M phases were determined using a computer program ModFitLT (Verity House Soft-ware, Topsham, ME, U.S.A.) and the percentage of cell death was calculated from the number of cells in sub-G 1 phase.
Flow Cytometry of Annexin V Binding Cells were precultured in serum-free medium in the presence or absence of NQ304 (10 mM) for 24 h, and then stimulated with 5% FBS for 24 h. Apoptosis was determined by staining with Alexa Fluor 488-labeled annexin V (Annexin-V-FLUOS Staining Kit, Roche). After the incubation, floating as well as adherent cells that were later trypsinized were pooled and centrifuged for 5 min at 1000ϫg. Pelleted cells were washed in cold phosphate-buffered saline (PBS). Thereafter, cells were centrifuged again for 5 min at 1000ϫg and resuspended in 100 ml Annexin-Binding Buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl 2 , pH 7.4) yielding a cell density of 1ϫ10 6 cells/ml. Five microliters of annexin V conjugate and 1 ml of 100 mg/ml PI working reagent were added to each 100 ml of cell suspension. The cells were incubated at room temperature for 15 min. After the incubation period, 400 ml of Annexin-Binding Buffer was added and mixed gently, and the samples were kept on ice. The stained cells were analyzed by flow cytometry, where the fluorescence emission was measured at 530 nm (Alexa Fluor 488). The rate of cells was determined using a computer program ModFitLT (Verity House Soft-ware, Topsham, ME, U.S.A.).
DNA Fragmentation Assays Genomic DNA was extracted using G-DEX TM Genomic DNA extraction kits according to the manufacturer's instructions (Intron Biotech, Seoul). In brief, cells were trypsinized, collected, rinsed twice with cold PBS, and lysed at 65°C for 10 min using lysis buffer. The obtained DNA was then incubated with RNase A (100 mg/ml) at 37°C for 1 h, treated with 100% isopropanol, and precipitated by centrifugation at 12000ϫg for 30 min at 4°C. DNA pellets were then washed with 70% ethanol and dissolved in DNA hydration buffer containing TE buffer. DNA concentrations were determined by spectrophotometry at 260 nm. The 20 mg of DNA was electrophoresed for 3 h at 30 V in a 1.8% agarose gel containing ethidium bromide. DNA fragmentation bands were photographed under UV light (Hoffer, San Francisco, CA, U.S.A.) and images were captured on Polaroid film.
RNA Isolation and Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Total RNA was isolated by using a single-step procedure using guanidine isothiocyanate-phenol-chloroform extraction and TRIzol reagent (Gibco-BRL). 10) In brief, 1 mg of total RNA was reverse-transcribed to synthesize single strand cDNA using a First-strand synthesis system kit (Gibco-BRL). Subsequently, 2 ml of the RT reaction products were subjected to PCR in order to coamplify a fragment of c-fos (sense; 5Ј-CCCCTGTCAACA-CACAGGAC-3Ј, antisense; 5Ј-GCAAT-CTCGGTCTGCA-ACGC-3Ј), 27) p21 cip1 (sense; 5Ј-TATGCCGTCGTCTGTT-CGGT-3Ј, antisense; 5Ј-TCTGTTAGGCTGGTCTGCCT-3Ј) 28) and p27 kip1 (sense; 5Ј-GTCAAACGTGAGAGTGTC-TA-3Ј, antisense; 5Ј-CAAATGCCGGTCCTCAGAGT-3Ј). 29) The GAPDH gene was used as an internal control (sense; 5Ј-CCTGCACCACCAACTGCTTA-3Ј, antisense; 5Ј-GAT-GCCAGTGAGCTTCCCGT-3Ј). 30) After an initial denaturation step at 94°C for 5 min, PCR was performed over 24 cycles (94°C/30 s, 58°C/30 s and 72°C/1 min) for c-fos, p21 cip1 , p27 kip1 and GAPDH. The images were captured on Polaroid film. The expressions of c-fos, p21 cip1 and p27 kip1 were normalized versus GAPDH. Band intensities were quantified using Scion-Image software operating in the Windows environment.
Immunoblotting SDS-PAGE was performed on cell lysates using 7.5-10% acrylamide gels according to the method devised by Laemmli. 31) Proteins were transferred to PVDF membranes (Millipore Corp.) and membranes were blocked overnight at 4°C in Tris-buffered saline containing 0.1% Tween 20 (TBS/T) and 5% skimmed milk powder. Membranes were then incubated with 1 : 2000 diluted phospho-ERK1/2, phospho-Akt, ERK1/2, or Akt antibodies. Blots were washed with TBS/T, and then incubated with a 1 : 5000 dilution of horseradish peroxidase-conjugated antimouse IgG or anti-rabbit IgG antibodies (New England Biolabs, MA, U.S.A.). Proteins were detected using an enhanced chemiluminescence (ECL) western blotting detect reagent (Amersham Biosciences). Band intensities were quantified using Scion-Image software operating in the Windows environment.
Electrophoretic Mobility Shift Assays (EMSA) EMSAs were performed by using a slight modification of a previously described method. 32) Briefly, cells were washed three times with ice-cold phosphate buffered saline (PBS, pH 7.6) and pelleted. Pellets were resuspended in 400 ml of cold buffer containing 10 mM HEPES, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol (DTT), and 0.2 mM phenylmethylsulfonyl fluoride (PMSF), and then centrifuged at 15000ϫg for 6 min to remove everything except nuclei. Nuclear pellets were resuspended in a second buffer containing 20 mM HEPES, 20% glycerol, 420 mM NaCl, 0.2 mM EDTA, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, and 0.2 mM PMSF, centrifuged at 15000ϫg for 6 min; at this stage the supernatant contained nuclear proteins. Protein levels were determined using a modification of the Bradford method (Bio-Rad Bulletin 1177, Bio-Rad, CA, U.S.A.). The DNA binding activity of AP-1 was assayed according to the manufacturer's instructions (Promega Co., WI, U.S.A.). In brief, 10 mg of nuclear protein was incubated in 25 ml total volume of incubation buffer (10 mM Tris, pH 7.5, 100 mM NaCl, 1 mM DTT, 4% glycerol, 0.08 mg/ml salmon sperm DNA) at 4°C for 15 min, and this was followed by another 20 min incubation with 250 mCi [g-32 P] ATP-labeled oligonucleotide containing AP-1 binding site at room temperature. The DNA-protein binding complexes obtained were run on a 6% non-denatured polyacrylamide gel at 150 V for 1 h. Gels were then dried and autoradiographed using Kodak MR Film at Ϫ80°C overnight.
Statistical Analysis The experimental results are expressed as meansϮS.D. One-way analysis of variance (ANOVA) was used for multiple comparisons, and this was followed by Dunnett's test. Differences were considered significant at the * p<0.05 or * * p<0.01 level as indicated.
RESULTS
NQ304 Inhibited DNA Synthesis and Cell Proliferation
We assessed the inhibitory effect of NQ304 on serum-induced VSMC proliferation. VSMC numbers in culture were determined after 24, 48, or 72 h of stimulation with 5% FBS. Pre-treatment of VSMCs with 1, 5 or 10 mM of NQ304 for 24 h also resulted in significant cell number decreases, i.e., inhibition percentages were 44.75Ϯ10.77, 73.85Ϯ6.38 and 89.77Ϯ6.52% at NQ304 concentrations of 1, 5 and 10 mM, respectively (Fig. 1A) . In addition, stimulation of cells with 5% FBS increased cell numbers in a time-dependent manner, and pre-treatment with 10 mM NQ304 before stimulation with 5% FBS completely inhibited this increase in cell number at 72 h (Fig. 1B) 3 H]-thymidine incorporation into DNA in a concentration-dependent manner, and this inhibition was significant at 5 and 10 mM (Fig. 1C) .
NQ304 did not Affect Apoptotic and Necrotic Cell Death To evaluate whether the reduction in the cell proliferation assay was not only caused by induction of cell death, we assessed the percentage of sub-G 1 in cell cycle phase. VSMCs were pre-treated with NQ304 (10 mM) in serum-free Fig. 1 . Effect of NQ304 on Serum-Induced Cell Proliferation (A, B) Effects of NQ304 on serum-induced VSMC cell numbers. Cells were precultured in serum-free medium in the presence or absence of NQ304 (1-10 mM) for 24 h, and then stimulated with 5% FBS for 24-72 h. Cells were trypsinized and then counted using a hemocytometer. (C) Effects of NQ304 on DNA synthesis in serum-induced VSMCs. Cells were pre-cultured in serum-free medium in the presence or absence of NQ304 (1-10 mM) for 24 h, and then stimulated with 5% FBS for 20 h. medium for 24 h, and then were stimulated with 5% FBS for 24 h. Sub-G 1 phase was analyzed for cell death effects, but percentages of cell death (sub-G 1 ) were not altered significantly by these treatments (Fig. 2A) . Since anti-proliferation is often accompanied by apoptosis, we also measured the apoptotic effects of NQ304 in VSMCs using the same conditions. NQ304 at 10 mM did not induce Annexin-V binding (Fig. 2B ) and DNA fragmentation (Fig. 2C) in VSMCs, which is one index of apoptosis. These results indicate that NQ304 blocks VSMC proliferation without inducing apoptotic or necrotic cell death.
NQ304 Induced Cell Cycle Arrest on G 0 /G 1 Phase Since growth factors regulate cell cycle progression, we assessed whether NQ304 causes cell cycle arrest. As shown in Table 1 , after 24 h of stimulation with 5% FBS, we observed an increase in the percentage of cells in the G 2 /M phase and a reduction in the G 0 /G 1 phase (DMSO; G 0 /G 1 -89.17%, S-1.64%, G 2 /M-9.18%, 5% serum; G 0 /G 1 -72.53%, S-10.56%, G 2 /M-16.89%). Moreover, the pre-incubation of VSMCs with NQ304 (10 mM) caused a significant accumulation of cells in the G 0 /G 1 phase, to the same extent as that observed for serum free media, indicating complete cell cycle arrest (5% serumϩNQ304; G 0 /G 1 -86.81%, S-3.99%, G 2 /M-9.18%). This effect strongly correlates with the observed inhibitory effects of NQ304 on VSMC counts and [ Kip1 . To analyze the molecular mechanisms which lead to the observed G 1 -phase block after NQ304 treatment, we determined the gene expression status of cell cycle inhibitors by western blot analysis. 13, 33) As shown in Fig 3, preincubation of NQ304 was found to lead to marked inductions of p21 cip1 and p27 kip1 mRNA in a concentration-dependent manner during 5% FBS stimulation.
NQ304 Inhibited the Expression of c-fos mRNA and the Activity of AP-1 DNA Binding Growth factors like PDGF-BB are known to stimulate the transient expression of c-fos, which is a known proto-oncogene. In addition, the activation of AP-1 (a transcriptional factor) DNA-binding is known to regulate c-fos mRNA expression, and to be required for cell proliferation. 11, 34) Therefore, to examine the mechanism underlying the anti-proliferative effect exerted by NQ304, we investigated whether NQ304 could suppress serum-induced c-fos expression. As shown in Fig. 4A , 5% FBS-induced c-fos mRNA expressions were decreased concentration-dependently by NQ304. Moreover, consistent with the observed c-fos expressional inhibition by NQ304, 5% FBS-induced AP-1 binding activation was also strongly inhibited in 10 mM NQ304-treated VSMCs (Fig. 4B) .
The Antiproliferative Effect of NQ304 was Induced by ERK 1/2 and Akt Pathway Suppressions We next examined whether NQ304 affects the activation of MAPK (ERK1/2) and the PI3K signaling pathway, which are upstream signaling pathways in the regulation of c-fos and AP-1 binding activation. VSMCs were precultured in the presence or absence of NQ304 (1-10 mM) in serum-free medium for 24 h, and then stimulated with 5% FBS. The 5% FBS-induced phosphorylations of ERK 1/2 and Akt were found to be significantly inhibited by NQ304 (1-10 mM) in a concentration-dependent manner (Fig. 5) .
DISCUSSION
Vascular smooth muscle cell (VSMC) proliferation is an important process for plaque formation in primary atherosclerosis. 1) Moreover, multiple growth factors and cytokines have been found to regulate vascular cell proliferation, platelets, inflammatory cells, damaged vascular cells, and activated VSMC which secrete growth factors and cytokines that trigger signaling pathways. 35) The aim of this study was to assess the effect of a newly synthesized 1,4-naphthoquinone derivative on the proliferation of serum-induced rat aortic VSMCs. The anti-proliferative effects of 1,4-naphthoquinone derivatives on rat aortic VSMCs were examined by direct cell counting and [ 3 H]-thymidine incorporation assays, and we found that 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304) is a potent growth inhibitor of VSMCs (Fig. 1) . However, the anti-proliferative effect of NQ304 on VSMCs was shown not to be due to apoptotic or necrotic cell death, as demonstrated by flow cytometry and DNA fragmentation analysis (Fig. 2) .
After vascular injury, VSMCs are stimulated to divide in response to mitogens, and that they exit the G 1 phase and enter the S phase. 12) As shown by cell cycle distribution in our study, the anti-proliferative effect of NQ304 is associated with an accumulation of cells in G 0 /G 1 phase of the cycle (Table 1) . We also observed elevated p21 cip1 and p27 kip1 mRNA levels, inhibitors of the cell cycle G 1 phase, by NQ304 (Fig. 3) . For example, 2-(2-mercaptoethanol)-3-methyl-1,4-naphthoquinone, was reported to be a potent inhibitor of tumor cell growth, and this compound also arrested cell cycle progression at both G 1 and G 2 /M levels. 24) Our data was agreed with a potent inhibitor of tumor cell growth, 2-(2-mercaptoethanol)-3-methyl-1,4-naphthoquinone. Based on these results, we believe that NQ304 may mediate cell cycle G 1 phase by upregulating p21 cip1 and p27 kip1 . Since NQ304 blocks VSMC proliferation without inducing cellular toxicity or apoptosis (Fig. 2) , we hypothesized that the antiproliferative effect of NQ304 is causally related to the modulation of the signaling cascade involved in cell cycle progression and proliferation.
To explore the mechanism which NQ304 inhibited VSMC proliferation, we observed the effect of NQ304 on serum-induced signaling pathways in VSMCs. Growth factors and cytokines are known to stimulate the transient expression of cfos and AP-1 DNA-binding activity, and it is also required for cell proliferation and tumor promotion.
11,34,37) Therefore, we examined whether the anti-proliferative effect of NQ304 might be achieved via the down-regulation of the c-fos gene expression and AP-1 activation. NQ304 suppressed seruminduced AP-1 DNA-binding activity (Fig. 4B) , and we also observed a decreased c-fos mRNA level (Fig. 4A) . Based on these results, we believe that NQ304 may mediate cell cycle progression and proliferation by downregulating c-fos and inhibiting AP-1 binding activity. ERK 1/2 and Akt, major signal transducing molecules regulate cellular proliferation, differentiation, and apoptosis. 8, 9) These are upstream signaling pathways in the regulation of cfos and AP-1 binding activation. Our present results showed that NQ304 significantly inhibited the activation of ERK 1/2 induced by 5% FBS in VSMCs (Fig. 5A) . We also found that NQ304 caused marked decreases in the serum-induced phosphorylations of Akt (Fig. 5B) , and that these were of the same pattern as that noted for the inhibition of ERK 1/2 phosphorylation by NQ304. Although, several studies have indicated that the ERK 1/2 and the Akt pathways appear to grow at distinct effectors, and that signaling pathways are regulated independently by various stimulators and intermediate signal transduction molecules. 10, 37) More recent studies have suggested that these two pathways also cross talk, possibly via an interaction between Raf and Akt. [38] [39] [40] Similarly, Ahn et al. reported that epigallocathechin-3 gallate (EGCG) blocks MAPK and PI3K signal transduction pathways in human smooth muscle cells. 37) Therefore, these results suggest that the inhibitory effect of NQ304 on the serum-induced VSMC proliferation might be attributed, at least in part, to its ability to inhibit ERK 1/2 and Akt activation. However, in our study, the precise mechanism of VSMC proliferation inhibition by NQ304 remains unknown and further studies are needed to determine the target site of NQ304.
In conclusion, our present study showed that the anti-proliferative activity of NQ304, a newly synthesized 1,4-naphthoquinone derivative, is mediated by the downregulations of AP-1 activation and c-fos expression via the suppression of the PI3K/Akt and ERK 1/2 signaling pathways in VSMCs. These findings may offer a new insight into the anti-cardiovascular agent of 1,4-naphthoquinone. Cells were pre-cultured in the presence or absence of NQ304 (1-10 mM) in serumfree medium for 24 h, and then stimulated with 5% FBS for 5 (A: ERK1/2) or 15 (B: Akt) min. Proteins from the total cells were resolved by SDS-PAGE, transferred to nitrocellulose, and blotted with an phospho-ERK1/2, phospho-Akt, ERK1/2 or Akt antibody. Relative densities were quantified by scanning densitometry, and the values shown represent meansϮS.D. from three different assays. * * p<0.01 compared with FBS alone.
